Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 53: 137-140, 2007. First published November 2, 2006; 10.1373/clinchem.2006.077263
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow 077263.Supplemental data
Right arrow All Versions of this Article:
clinchem.2006.077263v1
53/1/137    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, D.
Right arrow Articles by Gelb, M. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, D.
Right arrow Articles by Gelb, M. H.
Related Collections
Right arrow Molecular Diagnostics and Genetics
Right arrow General Clinical Chemistry
Right arrow Pediatric Clinical Chemistry
Right arrow Automation and Analytical Techniques
(Clinical Chemistry. 2007;53:137-140.)
© 2007 American Association for Clinical Chemistry, Inc.

Technical Briefs

Tandem Mass Spectrometry for the Direct Assay of Enzymes in Dried Blood Spots: Application to Newborn Screening for Mucopolysaccharidosis II (Hunter Disease)

Ding Wang1, Tim Wood2, Martin Sadilek1, C. Ronald Scott3, Frantisek Turecek1,a and Michael H. Gelb1,4,a

Departments of1 Chemistry, 3 Pediatrics, and 4 Biochemistry, University of Washington, Seattle, Washington; 2 Biochemical Genetics Laboratory, Greenwood Genetic Center, Greenwood, South Carolina

aaddress correspondence to M.H.G. at: Departments of Chemistry and Biochemistry, University of Washington, Campus Box 351700, Seattle, Washington 98195; fax 206-685-8665, e-mail gelb{at}chem.washington.edu; to F.T. at: Department of Chemistry, University of Washington, Campus Box 351700, Seattle, Washington 98195; fax 206-685-8665, e-mail turecek{at}chem.washington.edu


Abstract

Background: A treatment for mucopolysaccharidosis II (Hunter syndrome) has recently become available. Therefore, we developed a high-throughput assay method appropriate for newborn screening for the relevant enzyme, iduronate 2-sulfatase.

Methods: We synthesized a new iduronate 2-sulfatase substrate that can be used to assay the enzyme by use of tandem mass spectrometry together with an internal standard. The assay uses a dried blood spot on a newborn screening card as the enzyme source.

Results: When the assay was tested on dried blood spots, the iduronate 2-sulfatase activity measured for 13 patients with Hunter syndrome was well below the interval found for 57 randomly chosen newborns. The assay was more sensitive than previously reported iduronate 2-sulfatase assays.

Conclusions: This newly developed tandem mass spectrometry assay has the potential to be adopted for newborn screening of Hunter syndrome. This method also has the potential to be carried out in multiplex fashion to assay several different enzymes relevant to lysosomal storage diseases that are assayed in a single infusion into the mass spectrometer.




The following articles in journals at HighWire Press have cited this article:


Home page
 PediatricsHome page
R. Martin, M. Beck, C. Eng, R. Giugliani, P. Harmatz, V. Munoz, and J. Muenzer
Recognition and Diagnosis of Mucopolysaccharidosis II (Hunter Syndrome)
Pediatrics, February 1, 2008; 121(2): e377 - e386.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Association for Clinical Chemistry.